Quest Diagnostics Raises FY23 Revenue Guidance From $9.12B - $9.22B To $9.19B - $9.24B Vs. $9.18B Est.
Portfolio Pulse from Benzinga Newsdesk
Quest Diagnostics has increased its FY23 revenue guidance from $9.12B-$9.22B to $9.19B-$9.24B, which is higher than the estimated $9.18B.
October 24, 2023 | 10:53 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Quest Diagnostics' raised FY23 revenue guidance could potentially lead to a positive impact on its stock price.
Companies often see their stock prices increase when they raise their revenue guidance, as it signals stronger future performance. Given that Quest Diagnostics' new guidance is also higher than the estimate, it could lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100